Showing results (2151-2160 of 3,104) with videos related to
Sort By:
Pageof 311
Expert Review of Anticancer Therapy|October 10, 2019
The evolving role of maintenance therapy following autologous stem cell transplantation in multiple myelomaAlmuth Maria Anni Merz, Maximilian Merz, Jens Hillengass, et al.Expert Review of Anticancer Therapy|September 27, 2018
Health-related quality of life in cancer patients treated with PD-(L)1 inhibitors: a systematic reviewOmar Abdel-Rahman, Hani Oweira, Anwar GiryesExpert Review of Anticancer Therapy|August 18, 2020
Outcomes with anti-EGFR monoclonal antibodies in metastatic and recurrent anal squamous cell carcinomaJane E Rogers, Alexandre A A Jácome, Aki Ohinata, et al.Expert Review of Anticancer Therapy|August 18, 2020
Treatment of recurrent glioblastoma: state-of-the-art and future perspectivesVincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, et al.Expert Review of Anticancer Therapy|August 8, 2020
Combination therapy in advanced urothelial cancer: the role of PARP, HER-2 and mTOR inhibitorsVeronica Mollica, Ilaria Maggio, Antonio Lopez-Beltran, et al.Expert Review of Anticancer Therapy|August 11, 2020
Osteolytic metastasis in breast cancer: effective prevention strategiesChandi C MandalExpert Review of Anticancer Therapy|April 15, 2021
The development and clinical use of oral hypomethylating agents in acute myeloid leukemia and myelodysplastic syndromes: dawn of the total oral therapy eraMolly Schiffer, Jennifer Zhao, Aubrey Johnson, et al.Expert Review of Anticancer Therapy|April 8, 2021
Development of CpG oligodeoxynucleotide TLR9 agonists in anti-cancer therapyYizhen Jin, Yuxin Zhuang, Xiaowu Dong, et al.Expert Review of Anticancer Therapy|August 1, 2012
Long-term results of sorafenib in advanced-stage hepatocellular carcinoma: what can we learn from routine clinical practice?Rodolfo Sacco, Irene Bargellini, Barbara Ginanni, et al.Expert Review of Anticancer Therapy|August 1, 2012
Loss of miR-126 is crucial to pancreatic cancer progressionAdam E Frampton, Jonathan Krell, Jimmy Jacob, et al.Pageof 311